• UK's 2nd Covid wave started by young people, same scenario in India: Oxford Professor
    New Delhi, April 4 (IANS) In the UK, the second wave of the coronavirus was started by young people and it seems very likely that in India too, youngsters, who have been infected with the new strains of the virus, are spreading to more than one person, said Zhengming Chen, Professor of Epidemiology, Nuffield Department of Population Health, University of Oxford. Chen added that in the UK, a high proportion of patients have long Covid-19, but reasons for this phenomenon is not clear
  • Single-dose vax may be effective for Covid-19 survivors: Study
    New York, April 3 (IANS) A second of Covid-19 vaccination dose may not be needed for individuals who have successfully recovered from a prior coronavirus infection, suggests a study. The research, involving more than 260 individuals, showed that a single dose of the Pfizer-BioNTech vaccine for individuals who previously had Covid-19, can generate an immunologic response similar to that of individuals receiving the two-dose recommended sequence. The Pfizer and BioNTech vaccine is
  • Covid-19 masks: Layering, fitting & material matters, says study
    New York, April 3 (IANS) Love to wear fancy face masks to protect yourself from Covid-19? The types of material, fitting and the number of fabric layers used can significantly increase or decrease your risk of exposure to the deadly coronavirus, finds a new study. Materials, which combine fabric fibre density, a maze-like structure, and fibre surface chemistry can effectively reject submicron particles, which can stay in the air for hours and days and increase the risk of exposure,
  • 7 blood clot deaths in UK after AstraZeneca jab
    London, April 3 (IANS) After more than 18 million people have received vaccinations with AstraZeneca's jab in the UK, the country's health regulator said seven people had died due to rare blood clots, although the cause remains unclear. "The benefits in preventing a Covid-19 infection and its complications continue to outweigh any risks and the public should continue to get their vaccine when invited to do so," dpa news agency quoted June Raine, Chief Executive of
  • Why eating potato chips, chocolates may harm your kidneys
    Sydney, April 2 (IANS) Love to binge on potato chips, bread, bakery products and chocolate? Then beware, as a new rodent-based study revealed that eating processed foods can cause leaky gut syndrome, which in turn increases the risk of kidney disease. The study, led by researchers at Monash University in Australia, showed that heat-treated or processed foods are rich in harmful chemical compounds called Advanced Glycation End Products (AGEs). These chemicals give the browned, roaste
  • 1 COVID patient can infect 400 people: Maha health official
    New Delhi, April 2 (PTI): The head of Maharashtra's COVID-19 task force Dr Sanjay Oak on Thursday said a COVID-19 patient can infect 400 people, and hence, there is no alternative to masks, hygiene and social distancing. Speaking to reporters, Oak said a new range of symptoms such as common cold, mild body ache and fatigue has emerged in COVID-19 patients in the state. "The coronavirus infection generally spreads through our nose. One COVID-19 patients can infect at leas
  • New portable test can spot Covid in 15 mins, track variants
    New York, April 1 (IANS) A team of scientists has developed a new portable, pocket-sized machine that can diagnose SARS-CoV-2, the virus that causes Covid-19, in just 15 minutes. Globally, Covid-19 has infected nearly 129 million people and claimed 2.81 million lives. The new test -- NIRVANA -- can produce positive and negative results of 96 samples of Covid-19, influenza A, human adenovirus, and non-SARS-CoV-2 human coronavirus -- in real time. And within three hours, it can track
  • Pfizer-BioNTech Covid vax shows 100% efficacy in 12-15 yrs old
    New York, March 31 (IANS) Pharmaceutical companies Pfizer and BioNTech on Wednesday announced that their Covid-19 vaccine -- BNT162b2 -- demonstrated 100 per cent efficacy and robust antibody responses in a Phase 3 trial in adolescents between 12 to 15 years old. The Phase 3 clinical trial enrolled 2,260 adolescents aged between 12 to 15 years old in the US. "We share the urgency to expand the authorisation of our vaccine to use in younger populations and are encouraged by t
  • Peanut butter for weight loss
    New Delhi, March 31 (IANSlife) Peanut butter has multiple health benefits -- it has an enviable combination of protein and fibres. The driving factor in this growth is that consumers today are consciously aware of their nutritional intake. Our lives are packed with multiple routine activities, mainly the athletes, gym goers etc and protein intake becomes essential for sustained energy. A 2017 survey shows that 73 per cent of Indians are deficient in protein while above 90 per cent a
  • Mutations could render Covid vax ineffective in a year: Experts
    New York, March 30 (IANS) Mutations could render current Covid-19 vaccines ineffective in a year or less, according to two-thirds of 77 epidemiologists, virologists and infectious disease specialists from 28 countries surveyed by People's Vaccine Alliance. The results published on Tuesday deliver a stark warning of the risk the world is taking by failing to ensure all countries have sufficient vaccines to protect people from Covid-19. Of those surveyed, almost a third gave a
  • Diabetes drug may be new weapon against HIV
    New York, March 30 (IANS) A team of researchers has discovered an important vulnerability of the AIDS-causing retrovirus HIV, and has shown in preclinical experiments that a widely used diabetes drug, metformin, seems able to exploit this vulnerability. The findings, published in the journal Nature Immunology, suggests that HIV (human immunodeficiency virus), when it infects immune cells called CD4 T cells, helps fuel its own replication by boosting a key process in the cells' p
  • Added sugar linked to liver disease among children
    New York, March 30 (IANS) Restricting excessive consumption of added sugars may represent an early and important target by which non-alcoholic fatty-liver disease (NAFLD) risk can be reduced among children, said researchers. The study, published recently in the journal Pediatric Obesity, indicated that NAFLD is associated with both a lack of exercise, and excessive consumption of sucrose, the scientific name for table sugar, which is comprised of both fructose and glucose. While
  • Covid-19 strains don't appear to be highly variable: Expert
    New York, March 28 (IANS) As the emergence of new Covid-19 variants from different parts of the world complicate the fight against the pandemic, there appears to be some silver lining now. This is because an expert has found that the different strains of SARS-CoV-2, the virus responsible for the disease, do not appear to be highly variable. Writing an opinion piece in the magazine 'Scientific American', evolutionary microbiologist, Vaughn Cooper, said that the evidence sugge
  • Sensory loss ups depression risk in women
    London, March 27 (IANS) Women who suffer from vision, hearing or dual sensory loss are more than twice as likely to report depression and anxiety than men with similar issues, a new study suggests. The study, published in the International Journal of Geriatric Psychiatry, indicated that the prevalence of depression and anxiety was between 2 and 2.56 higher in women compared to men. "Our study found that while sensory loss, particularly both vision and hearing loss, results i
  • Serum Institute's 2nd Covid vax likely to be launched in Sep
    New Delhi, March 27 (IANS) Serum Institute of India, the world's biggest Covid-19 vaccine maker, is hopeful to launch Covovax by September this year, CEO Adar Poonawalla announced on Saturday. "Covovax trials finally begin in India; the vaccine is made through a partnership with Novavax and Serum Institute of India," said Adar Poonawalla. He further said that it has been tested against African and UK variants of Covid-19 and has an overall efficacy of 89 per cent. &
  • Cholesterol could be key to new Alzheimer's, diabetes therapies
    NEW YORK, MARCH 26 (IANS): Examining the role of cholesterol in both Alzheimer's disease and Type-2 diabetes, researchers have identified a small molecule that may help regulate cholesterol levels in the brain, making it a potential new therapeutic target for Alzheimer's disease. There is no known cure for Alzheimer's disease and in the last decade, scientists have found increasing evidence linking the underlying causes of Type 2 diabetes and Alzheimer's disease.
  • How seasonal shifts affect your skin
    New Delhi, March 25 (IANSlife) As the weather changes, most of us notice changes in the texture and appearance of our skin as well. A shift from dry to oily feeling, increase in skin flare ups and breakouts are common experiences. Seasonal changes bring with them a lot of environmental changes as well. Along with temperature shifts, humidity levels also fluctuate. The type of pollens or allergic elements in the environment also change, so do microorganisms. All these changes do have
  • 3 common antiviral drugs potentially effective against Covid
    NEW YORK, MARCH 25 (IANS): A team of researchers has found that three commonly used antiviral and antimalarial drugs are effective in vitro at preventing replication of SARS-CoV-2, the virus that causes Covid-19. The study, published in the journal ACS Omega, looked at three antiviral drugs that have proven effective against Ebola and the Marburg virus -- tilorone, quinacrine and pyronaridine. "We were looking for compounds that could block the entry of the virus into the ce
  • AstraZeneca confirms strong vaccine protection after US rift
    Washington, March 25 (AP) AstraZeneca insisted Wednesday that its COVID-19 vaccine is strongly effective even after counting additional illnesses in its disputed US study, the latest in an extraordinary public rift with American officials. In a late-night press release, AstraZeneca said it had recalculated data from that study and concluded the vaccine is 76 per cent effective in preventing symptomatic COVID-19, instead of the 79 per cent it had claimed earlier in the week. Just
  • Midlife loneliness may up dementia, Alzheimer's risk
    NEW YORK, MARCH 24 (IANS): Being persistently lonely during midlife appears to make people more likely to develop dementia and Alzheimer's Disease (AD) later in life, a new study finds. The study, published in the journal 'Alzheimer's & Dementia', also indicated that people who recover from loneliness appear to be less likely to suffer from dementia. "Whereas persistent loneliness is a threat to brain health, psychological resilience following adverse lif